Assertio Holdings, Inc.

Assertio Holdings, Inc.verified

ASRT

Price:

$0.8625

Market Cap:

$82.35M

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately seve...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1997-12-03

Stock Exchange

NASDAQ

Ticker

ASRT

The Enterprise Value as of December 2024 (TTM) for Assertio Holdings, Inc. (ASRT) is 84.08M

According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 84.08M. This represents a change of -1.42% compared to the average of 85.30M of the last 4 quarters.

Assertio Holdings, Inc. (ASRT) Historical Enterprise Value (quarterly & annually)

How has ASRT Enterprise Value performed in the past?

The mean historical Enterprise Value of Assertio Holdings, Inc. over the last ten years is 652.90M. The current 84.08M Enterprise Value has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), ASRT's Enterprise Value was at its highest in in the September 2016 quarter at 2.11B. The Enterprise Value was at its lowest in in the March 2020 quarter at 4.62M.

Quarterly (TTM)
Annual

Average

652.90M

Median

500.07M

Minimum

43.47M

Maximum

1.69B

Assertio Holdings, Inc. (ASRT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Assertio Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 179.90%

Maximum Annual Enterprise Value = 1.69B

Minimum Annual Increase = -78.69%

Minimum Annual Enterprise Value = 43.47M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202343.47M-78.69%
2022204.05M56.01%
2021130.79M29.42%
2020101.06M-74.58%
2019397.55M-42.00%
2018685.45M-33.68%
20171.03B-37.13%
20161.64B-2.53%
20151.69B179.90%
2014602.59M85.84%

Assertio Holdings, Inc. (ASRT) Average Enterprise Value

How has ASRT Enterprise Value performed in the past?

The current Enterprise Value of Assertio Holdings, Inc. (ASRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

126.10M

5-year avg

175.38M

10-year avg

652.90M

Assertio Holdings, Inc. (ASRT) Enterprise Value vs. Peers

How is ASRT’s Enterprise Value compared to its peers?

Assertio Holdings, Inc.’s Enterprise Value is greater than Agile Therapeutics, Inc. (7.87M), less than Amneal Pharmaceuticals, Inc. (6.18B), greater than AcelRx Pharmaceuticals, Inc. (-729188.00), less than Lifecore Biomedical, Inc. (406.07M), less than Ironwood Pharmaceuticals, Inc. (1.27B), less than Neurocrine Biosciences, Inc. (13.77B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Esperion Therapeutics, Inc. (571.51M), less than ANI Pharmaceuticals, Inc. (1.61B), less than Alkermes plc (4.74B), less than Dr. Reddy's Laboratories Limited (1.16T), less than Collegium Pharmaceutical, Inc. (1.78B), less than Pacira BioSciences, Inc. (1.29B), less than Intra-Cellular Therapies, Inc. (8.58B), less than Catalent, Inc. (16.13B), less than Amphastar Pharmaceuticals, Inc. (2.27B), less than Alvotech (4.84B), greater than Eagle Pharmaceuticals, Inc. (19.21M), less than Evolus, Inc. (604.34M),

Build a custom stock screener for Assertio Holdings, Inc. (ASRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Assertio Holdings, Inc. (ASRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Assertio Holdings, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Assertio Holdings, Inc. (ASRT)?

What is the 3-year average Enterprise Value for Assertio Holdings, Inc. (ASRT)?

What is the 5-year average Enterprise Value for Assertio Holdings, Inc. (ASRT)?

How does the current Enterprise Value for Assertio Holdings, Inc. (ASRT) compare to its historical average?